Today: 8 June 2026
Gold price whipsaws: buyers rush back after brutal selloff, lifting GLD and miners
3 February 2026
2 mins read

Gold price whipsaws: buyers rush back after brutal selloff, lifting GLD and miners

New York, Feb 3, 2026, 10:07 EST — Regular session

  • Spot gold bounces back roughly 5% following a two-day drop that pushed prices to their lowest in a month
  • Gold-linked ETFs surge in early New York trading, mirroring the rise in bullion
  • CME margin increases, the Fed chair shuffle, and a data delay caused by a U.S. government shutdown have returned to the spotlight

Gold prices surged Tuesday, marking their largest daily gain since 2008 as buyers stepped back in following a sharp two-day selloff.

This rebound is crucial since last week’s drop seemed driven by forced risk-cutting rather than a clear shift in fundamentals. Margin calls hit futures traders, ETFs faced outflows, and those moves snowballed, dragging gold stocks down with them.

CME Group boosted margin requirements on precious metals futures—the cash collateral traders need to hold positions—with the new levels kicking in after Monday’s close. Spot gold dropped 4.8% on Monday, while silver plunged 9.2%, pressured by a stronger dollar following gold’s nearly 10% decline on Friday.

Futures positioning reflects some of the recent shakeout. Open interest in COMEX gold futures—the tally of outstanding contracts—was 425,082 at 10:00 a.m. Tuesday, dropping 10,231 from the previous session, according to Associated Press market data.

Spot gold jumped 5.3% to $4,913.59 an ounce by 7:34 a.m. ET, bouncing back from Monday’s low of $4,403.24. Meanwhile, U.S. gold futures for April climbed 6.1% to $4,936.20. “The market was oversold … what we see today is a rebound,” said Peter Fertig, a Quantitative Commodity Research analyst. Saxo Bank’s Ole Hansen flagged $5,000 as the next key “retracement” level — a technical point measuring how much of a prior move has been reversed. Reuters

Gold’s drop came after U.S. President Donald Trump nominated Kevin Warsh to replace Federal Reserve Chair Jerome Powell in May, traders said. Warsh is widely seen as likely to push for rate cuts while also tightening the Fed’s balance sheet — a combination that usually boosts the dollar and puts pressure on dollar-denominated gold.

SPDR Gold Shares climbed roughly 5.9% to around $452. VanEck Gold Miners ETF jumped about 4.6%, hitting near $98. Newmont rose close to 3.1%, Agnico Eagle increased by about 3.7%, and Wheaton Precious Metals added roughly 4.0% in early U.S. trading.

Activity in the sector’s deal pipeline remains robust despite volatile prices. Eldorado Gold announced Monday it’s acquiring Canada’s Foran Mining for C$3.8 billion. Foran CEO Dan Myerson highlighted that the move would provide its McIlvenna Bay project with “the scale and financial strength” needed to speed up growth. Reuters

Risks remain. Analysts caution the selloff could continue if the dollar strengthens or if rising margins trigger another round of liquidations. City Index market analyst Fawad Razaqzada said it’s “far too early” to claim gold has hit its bottom. Reuters

Macro traders found themselves without a clear short-term guide this week. The Labor Department announced delays for both the January employment report, originally set for Friday, and the December job-openings report, due Tuesday, due to a partial U.S. government shutdown.

Markets are watching to see if bullion can break back above $5,000 and hold it, while also scanning Washington for any sign of restored data flow. The January CPI release is due Feb. 11—provided the shutdown wraps up soon enough for the Labor Department to put it out.

Stock Market Today

  • KOSPI Index Plunges Amid Global Market Turmoil
    June 8, 2026, 9:07 AM EDT. South Korea's KOSPI experienced a sharp crash triggered by margin stress in chip stocks and a circuit breaker trading halt. The selloff in global markets was fueled by a strong U.S. jobs report signaling prolonged high interest rates, fears of a yen carry trade unwind amid Bank of Japan tightening, and a crypto selloff following Zcash network vulnerabilities. U.S. futures rebounded slightly as chip stocks recovered, with investors focused on upcoming inflation data and SpaceX's anticipated IPO. Rising Middle East tensions keep oil prices elevated near $94 per barrel. The volatile market reflects growing concerns over liquidity absorption from the SpaceX listing, geopolitical risks, and tightening monetary policies globally.

Latest articles

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

Plug Power Stock Faces a Make-or-Break Week After Friday’s 10% Drop

8 June 2026
Plug Power rose 2.95% to $3.31 in Monday pre-market trading after a $39.2 million federal tax credit sale tied to its St. Gabriel hydrogen facility, as investors await CEO Jose Luis Crespo’s June 11 update on liquidity and asset sales amid ongoing losses and a recent 10.69% stock drop.
ABAT Shares Jump on DOE’s $115M Lithium Grant Return

ABAT Shares Jump on DOE’s $115M Lithium Grant Return

8 June 2026
American Battery Technology Co shares soared 29.58% to $4.03 premarket after the U.S. Department of Energy fully reinstated a $115 million grant for its Nevada lithium refinery, restoring federal funding for the Tonopah Flats Lithium Project with no change to awarded funds or milestones, though risks remain from permitting, financing, and volatile lithium prices.
NANO Nuclear Stock Bounces, Investors Eye What’s Next

NANO Nuclear Stock Bounces, Investors Eye What’s Next

8 June 2026
NANO Nuclear Energy jumped 7.8% to $25.40 in premarket trading after a 9.9% Friday drop, as traders weighed fresh insider sales filings and recent regulatory progress on its KRONOS microreactor project; the company held $568.7 million in cash as of March 31, but faces sector-wide volatility and execution risks.
Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

Nurix Shares Jump Premarket on Roche $2.3 Billion Cancer Drug Deal

8 June 2026
Nurix soared 20.4% to $17.62 premarket after Roche agreed to pay $700 million up front in a bexobrutideg collaboration worth up to $2.3 billion, a major cash boost and external validation for Nurix’s lead blood cancer drug ahead of a planned Phase 3 trial, with Roche’s clinical and commercial backing now in play.
Microsoft stock price slips early: MSFT hit by Azure glitches as OpenAI spreads across clouds
Previous Story

Microsoft stock price slips early: MSFT hit by Azure glitches as OpenAI spreads across clouds

Constellation Software’s 48% slide has investors split as AI fears rattle software stocks
Next Story

Constellation Software’s 48% slide has investors split as AI fears rattle software stocks

Go toTop